Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO

Author:

Cremolini C.,Antoniotti C.,Lonardi S.,Bergamo F.,Cortesi E.,Tomasello G.,Moretto R.,Ronzoni M.,Racca P.,Loupakis F.,Zaniboni A.,Tonini G.,Buonadonna A.,Marmorino F.,Allegrini G.,Granetto C.,Masi G.,Zagonel V.,Sensi E.,Fontanini G.,Boni L.,Falcone A.

Funder

Gruppo Oncologico Nord Ovest

ARCO Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference15 articles.

1. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location;Bufill;Ann Intern Med,1990

2. Are right- and left-sided colon neoplasms distinct tumors?;Distler;Dig Dis,1997

3. Are there two sides to colorectal cancer?;Iacopetta;Int J Cancer,2002

4. ssociation of primary (1°) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti-epidermal growth factor receptor (αEGFR) therapy;Lee;J Clin Oncol,2016

5. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features;Missiaglia;Ann Oncol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3